A new horizon in the care of hemophilia A and B
MILAN (ITALPRESS) – With the publication of the AIFA in the Official Journal, marstacimab (Hympavzi trade name) is officially available in Italy under repayment. The drug, administered by subcutaneous means, once a week, through pre-filled pen, with fixed dosage, is […]
A new horizon in the care of hemophilia A and B Read More »










